liver cancer
Conditions
Interventions
Sponsors
the first affiliated hospital of Chongqing medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Meeting the diagnostic criteria for primary hepatocellular carcinoma; (2) Clear microvascular invasion by pathological histological examination; (3) Karnofsky functional status score of 70; (4) Child-Pugh grade A-B; (5) Clinical stage I-IIIa; (6) Patients with higher than normal postoperative serological tumor markers; (7) Patients were aware of the study and had signed the consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with co-morbidities of other primary malignancies; (2) Patients with autoimmune diseases; (3) Patients with hematologic disorders; (4) Patients with severe infectious diseases; (5) patients with severe cardiovascular diseases and renal and pulmonary insufficiency (6) Patients with recurrent hepatocellular carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate;Liver and kidney function, blood routine, coagulation function, tumor markers, C-reactive protein;quality of life;complication; | — |
Countries
People's Republic of China
Contacts
Public ContactDu Chengyou
the first affiliated hospital of Chongqing medical university
Outcome results
None listed